Novo Nordisk A/S Common Stock is a global healthcare company specializing in diabetes care. With a strong focus on research and development, the company offers a wide range of products and services for the treatment of diabetes and other chronic conditions. Novo Nordisk aims to improve the lives of millions of people living with diabetes through innovative solutions and patient-centered care.